GLISAXAPIN M (Saxagliptin 2.5mg, Metformin HCI ER 500mg)

Saxagliptin (2.5mg), Metformin HCI (ER) (500mg)
GLISAXAPIN M
Saxagliptin is an oral antidiabetic medication classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which increases the levels of incretin hormones in the body. Incretin hormones stimulate the release of insulin and reduce the production of glucagon, leading to better blood sugar control. Saxagliptin is typically prescribed in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.
Metformin HCI (ER): Metformin is an oral antidiabetic medication that belongs to the biguanide class. It is considered a first-line treatment for type 2 diabetes. Metformin helps lower blood sugar levels by reducing the production of glucose in the liver and improving insulin sensitivity in the body's tissues. Metformin HCI (ER) refers to the extended-release formulation, which releases the medication gradually over time, allowing for once-daily dosing. Extended-release formulations often help minimize gastrointestinal side effects commonly associated with immediate-release formulations of metformin.
GLISAXAPIN M is available in strength of 2.5 and 5mg.
STERIS PHARMA Generic medicines are generally more affordable than their brand-name counterparts. Generic medicines have the same active ingredients, dosage form, strength, and route of administration as their brand-name counterparts.
For further information please contact:
contact@sterispharma.com
Order now - https://www.sterisonline.com/product/glisaxapin-m-2-5-500-133433